| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/24/1992 | US5098535 Process for preparing 14-α-hydroxy-4-androstene-3,6,17-trione |
| 03/24/1992 | CA1298035C Antitumor amino acid and peptide derivatives of 1,4- bis¬(aminoalkyl andhydroxyaminoalkyl)amino|-5, 8-dihydroxyanthraquinones |
| 03/24/1992 | CA1297909C 1-(aminophenyl)-2-aminoethanone derivatives, the method for their preparation and their use in therapy |
| 03/24/1992 | CA1297901C Process for the production of aminocarnitines |
| 03/24/1992 | CA1297877C Benzofurancarboxamides useful as antiemetic or antipsychotic agents |
| 03/24/1992 | CA1297876C 3(2h)pyridazinone, process for its preparation and anti-allergic agentcontaining it |
| 03/24/1992 | CA1297875C2 Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h -receptor antagonists activity |
| 03/24/1992 | CA1297792C Fibrinolytic composition |
| 03/22/1992 | WO1992005162A1 Isoxazole compound, pharmaceutically acceptable salt thereof, and medicinal use thereof |
| 03/22/1992 | WO1992005151A1 Crystallization of optical isomers of leukotriene antagonists |
| 03/22/1992 | WO1992004896A1 Method of treating auto-immune diseases using gallium compounds |
| 03/22/1992 | WO1992004889A1 Effective solid non-lozenge anti-acid/anti-gas medicament |
| 03/22/1992 | CA2091897A1 Isoxazole compound, pharmaceutically acceptable salt thereof, and medicinal use thereof |
| 03/22/1992 | CA2091245A1 Crystallization of optical isomers of leukotriene antagonists |
| 03/22/1992 | CA2090231A1 Effective solid non-lozenge anti-acid/anti-gas medicament |
| 03/22/1992 | CA2069111A1 Method of treating auto-immune diseases using gallium compounds |
| 03/22/1992 | CA2069096A1 Enzymatic synthesis of oligonucleotides |
| 03/22/1992 | CA2051803A1 Aromatase inhibiting 4(5)-imidazoles |
| 03/22/1992 | CA2051766A1 Isoprenoid phospholipase a2 inhibitors and preparations comprising same |
| 03/22/1992 | CA2030039A1 Sustained release morphine preparation for rectal administration |
| 03/21/1992 | WO1992005186A1 Modified internucleoside linkages |
| 03/21/1992 | WO1992005149A1 Complexes of nitric oxide with polyamines |
| 03/21/1992 | CA2092002A1 Modified internucleoside linkages |
| 03/20/1992 | WO1992005164A1 Novel aminobenzosultam derivatives as lipoxygenase inhibitors |
| 03/20/1992 | CA2089740A1 Aminobenzosultam derivatives as lipoxygenase inhibitors |
| 03/20/1992 | CA2051781A1 Carboxylic acid esters of rapamycin |
| 03/20/1992 | CA2050054A1 7-oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease |
| 03/19/1992 | WO1992005187A1 NEW 17-β-OESTRADIOL DERIVATIVES, A METHOD OF PREPARING THEM, AND DRUGS CONTAINING THEM |
| 03/19/1992 | WO1992004432A1 3-substituted and 3,3-disubstituted 4-oxoretinoic acids and their esters |
| 03/19/1992 | WO1992004392A1 Polymers containing diester units |
| 03/19/1992 | WO1992004353A1 Cephalosporin derivatives and their homologues |
| 03/19/1992 | WO1992004350A1 Oxygenated quinoxalines |
| 03/19/1992 | WO1992004345A1 6- or 7- (2-IMINO-2-IMIDAZOLIDINE)-1,4-BENZOXAZINES AS ALPHA ADRENERGIC AGENTS |
| 03/19/1992 | WO1992004343A1 Novel tetrahydrobenzazole derivative |
| 03/19/1992 | WO1992004334A1 Compounds |
| 03/19/1992 | WO1992004332A1 Imidazole derivatives, their preparation and pharmaceutical compositions |
| 03/19/1992 | WO1992004331A1 Substituted 2 imidazolone derivatives, their preparation and pharmaceutical compositions |
| 03/19/1992 | WO1992004330A1 Substituted imidazoles, their preparation and pharmaceutical compositions |
| 03/19/1992 | WO1992004323A1 1,2,5,6-tetrahydropyridine oxime derivatives |
| 03/19/1992 | WO1992004316A1 Phenylethanolamines, drugs containing these compounds, and a method of preparing them |
| 03/19/1992 | WO1992004312A1 Process for making e/z mixtures of 2-(6-alkyl-bicyclo-[3.3.0]-octane-3-ylidene)-acetic acid derivatives with a preponderant proportion of the e-isomers |
| 03/19/1992 | WO1992004309A1 Novel 15,16-seco-19-nor progestins |
| 03/19/1992 | WO1992004055A1 Immunosuppressant composition |
| 03/19/1992 | WO1992004045A1 Novel cholecystokinin antagonists, their preparation and therapeutic use |
| 03/19/1992 | WO1992004038A1 Pro-drugs for cck antagonists |
| 03/19/1992 | WO1992004030A1 Stock solution of sucralfate suspended in water and production thereof |
| 03/19/1992 | WO1992004029A1 Composition containing silver sulfadiazine and benzocaine for use in the treatment of wounds following laser surgery |
| 03/19/1992 | WO1992004027A1 Pharmaceutical compositions for use in treating aids |
| 03/19/1992 | WO1992004026A1 Use of 4-hydroxyphenyl-thioethers for stimulating superoxide generation |
| 03/19/1992 | WO1992004022A1 Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders |
| 03/19/1992 | WO1992004020A1 Method of inhibiting superoxide generation |
| 03/19/1992 | WO1992004018A1 Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals |
| 03/19/1992 | WO1992004017A1 Cis-n-(2-aminocyclohexyl)benzamide and their enantiomers as anticonvulsants |
| 03/19/1992 | WO1992004012A1 Antiemetic therapy |
| 03/19/1992 | WO1992004011A1 Dosage form for time-varying patterns of drug delivery |
| 03/19/1992 | WO1992004008A1 Composition for treating ocular pain |
| 03/19/1992 | WO1992003925A1 Treatment process for promoting weight loss employing a substituted δ5-androstene |
| 03/19/1992 | WO1992000740A3 Bis-dioxopiperazines and their use as protection agents |
| 03/19/1992 | WO1992000287A3 Analogs of carbonic anhydrase inhibitors and their use as topical iop inhibitors |
| 03/19/1992 | WO1991019704A3 Oxa- and thiazolidinedione hypoglycemic and hypocholesterolemic agents |
| 03/19/1992 | WO1991019692A3 Calcium citrate malate composition |
| 03/19/1992 | WO1990012577A3 Topical anti-angiogenic as hair growth inhibitors |
| 03/19/1992 | DE4120296A1 Plant-based combination for use against aids - contains tannic acid, glycosidecpd., bitter substances, ethereal oils, limonene, M-cresol, etc. |
| 03/19/1992 | DE4029499A1 Neue 17-(beta)-oestradiolderivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel New 17- (beta) -oestradiolderivate, process for their production and pharmaceutical compositions containing them |
| 03/19/1992 | DE4028957A1 Antibacterial therapeutic contg. EDTA - used for care of the mouth and throat esp. for treating parodontopathy |
| 03/19/1992 | CA2289222A1 Gene therapy for cystic fibrosis |
| 03/19/1992 | CA2091268A1 17-.beta.-oestradiol derivatives, processes for their preparation and medicaments containing these compounds |
| 03/19/1992 | CA2090759A1 Treatment process for promoting weight loss employing a substituted 5-androstene |
| 03/19/1992 | CA2088195A1 Cholecystokinin antagonists, their preparation and therapeutic use |
| 03/19/1992 | CA2073003A1 Composition for treating ocular pain |
| 03/19/1992 | CA2071917A1 15,16-seco-19-nor progestins |
| 03/19/1992 | CA2051479A1 Heteroarylmethylbenzenes |
| 03/18/1992 | WO1992005163A1 5-trifluoroacylamino-2-aryl oxazoles |
| 03/18/1992 | WO1992005153A1 Antiproliferative substituted naphthalene compounds |
| 03/18/1992 | WO1992004897A1 1-substituted phenoxathiin derivatives as antidepressants |
| 03/18/1992 | EP0475898A1 Azacyclic compounds |
| 03/18/1992 | EP0475896A1 Polycyclic compounds |
| 03/18/1992 | EP0475895A1 Acyl derivatives of rifamycins and their use as medicaments |
| 03/18/1992 | EP0475894A1 Gemfibrozil formulations |
| 03/18/1992 | EP0475851A1 Antioxydant system based on basic aminoacid and a tocopherol |
| 03/18/1992 | EP0475844A1 Use of N-(1.hexahydroazepinylalkyl) acetamides for the manufacture of medicaments for the treatment of disorders of the cholineogic transmission |
| 03/18/1992 | EP0475755A1 3-Aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof |
| 03/18/1992 | EP0475706A1 Novel squalene synthetase inhibitors |
| 03/18/1992 | EP0475664A1 Lubricant composition and use thereof |
| 03/18/1992 | EP0475577A1 Hydrogenated rapamycin derivatives |
| 03/18/1992 | EP0475527A2 Aryl-fused and hetaryl-fused-2, 4-diazepine and 2, 4-diazocine antiarrhythmic agents |
| 03/18/1992 | EP0475518A1 28-Hydroxy ivermectin aglycone |
| 03/18/1992 | EP0475506A1 Pharmaceutical formulation containing a benzoyl urea derivative |
| 03/18/1992 | EP0475482A1 Stabilized solid chemical compositions |
| 03/18/1992 | EP0475473A2 Novel anthracyline compounds having anti-tumour activity, novel intermediates for the preparation of these anthracycline compounds, as well as compositions containing said active anthracycline compounds |
| 03/18/1992 | EP0475456A1 Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and a process for preparing the same |
| 03/18/1992 | EP0475413A2 Carbocyclic nucleoside analogs useful as immunosuppressants |
| 03/18/1992 | EP0475411A1 Novel carbocyclic adenosine analogs useful as immunosuppressants |
| 03/18/1992 | EP0475383A2 Polysaccharide composition or polysaccharide having heparinoid activity, process for producing the same, and anticoagulant containing the same as active ingredient |
| 03/18/1992 | EP0475374A2 Use of branched chain amino acids to effect diaphragm contractility and fatigue |
| 03/18/1992 | EP0475352A1 3-(1H-Indazol-3-yl)-4-pyridinamines, a process and intermediates for their preparation and their use as medicaments |
| 03/18/1992 | EP0475291A1 A novel biologically active peptide derived from chicken (chicken CNP) |
| 03/18/1992 | EP0475290A1 A novel biologically active peptide derived from frog (frog CNP) |
| 03/18/1992 | EP0475231A1 Benzodiazepines |
| 03/18/1992 | EP0475214A1 Caffeic acid derivatives and pharmaceutical compositions containing the same |